Metronidazol Orifarm

Metronidazole, the active ingredient in Metronidazol Orifarm, is a nitroimidazole antibiotic presented as an oral tablet for systemic use. It treats anaerobic bacterial infections and certain protozoal infections in adults and children as prescribed.

GNH USA supplies Metronidazol Orifarm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metronidazole is used to manage infections caused by anaerobic bacteria and susceptible protozoa. - Bacterial vaginosis: eradicates the anaerobic bacteria responsible, relieving discharge and odor. - Trichomoniasis: eliminates Trichomonas vaginalis, curing infection and preventing recurrence. - Amoebiasis: destroys Entamoeba histolytica trophozoites, treating intestinal and extra‑intestinal disease. - Anaerobic bacterial infections: targets a broad range of anaerobes in intra‑abdominal, pelvic, skin and soft‑tissue infections. - Clostridioides difficile infection: reduces toxin‑producing bacteria, aiding resolution of mild to moderate disease.

Metronidazole may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Metallic taste: transient metallic sensation in the mouth. - Diarrhea: loose stools that usually resolve after therapy. - Abdominal pain: cramp‑like discomfort in the abdomen. - Headache: mild to moderate headache during treatment. - Loss of appetite: reduced desire to eat.

Serious or Rare Side Effects: - Seizures: rare neurologic events requiring immediate medical attention. - Peripheral neuropathy: tingling or numbness in extremities, potentially persistent. - Severe allergic reactions: anaphylaxis, swelling, or rash. - Stevens‑Johnson syndrome: severe skin blistering and detachment. - Pseudomembranous colitis: Clostridioides difficile overgrowth causing severe diarrhea. - Hepatotoxicity: elevated liver enzymes or liver injury.

Before prescribing Metronidazol Orifarm, clinicians should consider several safety factors. - Renal or hepatic impairment: adjust therapy and monitor function. - Alcohol consumption: avoid alcohol to prevent disulfiram‑like reactions. - Allergic history: assess for prior hypersensitivity to nitroimidazoles. - Pregnancy and breastfeeding: use only if benefits outweigh potential risks. - Concomitant CNS depressants: monitor for enhanced sedation. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Metronidazol Orifarm can affect, or be affected by, other medicines.

Major Interactions (Avoid): - Alcohol: may cause severe flushing, nausea, vomiting, and tachycardia. - Warfarin: potentiates anticoagulant effect, increasing bleeding risk. - Lithium: can raise lithium serum levels, leading to toxicity.

Moderate Interactions (Monitor Closely): - Phenytoin: may reduce metronidazole concentrations, lowering efficacy. - Oral contraceptives: may decrease hormonal effectiveness, consider backup contraception.